ENTITY
Celltrion Pharm

Celltrion Pharm (068760 KS)

119
Analysis
Health CareSouth Korea
Celltrion Pharm Inc. manufactures and sells pharmaceutical products. The Company products inclue drugs for for hepatic diseases, digestion, diabetes, cold and fever, anti-inflammatory, and veterinary medical products. Celltrion also provides pharmaceutical raw materials.
more
31 Mar 2020 13:10

Celltrion Merger: Potential Controversy from Healthcare's Inventory Situation

Celltrion held the annual general meeting on March 27. During this meeting, CEO Seo reaffirmed the merger between the three siblings. He...

Logo
504 Views
Share
24 Mar 2020 17:51

Short Covering - The New Normal

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 20 March 2020, the...

Logo
504 Views
Share
24 Mar 2020 07:30

Celltrion Seo's Projected Timeline for a COVID-19 Vaccine: Key Takeaways from PR

The three Celltrion siblings had quite a pleasant day yesterday. Celltrion Inc (068270 KS) was up 14.75%, while Celltrion Pharm (068760 KS) almost...

Logo
425 Views
Share
01 Feb 2020 13:41

Korea Stock Market Monthly Recap #44 (January 2020)

The top 10 events impacting the Korean stock market, economy, & politics in January were as follows: 1) NEW CORONAVIRUS (WUHAN VIRUS) 2)...

Logo
511 Views
Share
21 Jan 2020 17:51

Korea - Celltrion Shorts Increase, Semco Covering Continues

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 17 January 2020....

Logo
506 Views
Share
x